Tuesday, April 21, 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 402 - (OTC: $SKDI) (OTC: $CURR), (OTC: $PSYC) (OTCQX: $MRMD)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 402 - (OTC: $SKDI) (OTC: $CURR), (OTC: $PSYC) (OTCQX: $MRMD)

Delta, Kelowna, BC, April 21, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s podcast will be looking at a few public and private company announcements.

Sun Kissed Industries Inc. (OTC:SKDI), an emerging leader in the CBD Food and Beverage marketplace, announced that its recent acquisition, Products Group Inc, DBA/ Hakuna Supply, has completed expansion and installation of its new Clean Room facility, which includes a newly installed industrial mixer, a Nespresso Capsule filling machine, and a Bagged Coffee filling machine.
The new Clean Room facility has sharply increased the Company's revenues and productive output:            
     Nespresso Capsule production increased from 2,000/day to 10,000/day
     Bagged Coffee filling machine driving 500% increase in per day bagged coffee production
     New capability to produce single serve instant coffee pouches
     Cost of goods sold expected to drop approximately 30% on a per unit basis
"The results of our hard-working team have resulted in significantly increased output across all our product lines and decreased order-to-shipment time frames," commented Hakuna CEO, Ilan Freeman. "In addition, we have seen demand increase over the past couple of months ahead of our expanded marketing efforts."
The newly expanded and enhanced Clean Room went into full use at the beginning of April. Hakuna online sales have increased 30% since the COVID-19 'lock-downs'. The expanded facilities and new equipment, along with increased marketing investments, have Hakuna projecting increased revenues across all online product lines on a month-over-month and year-over-year basis.
Hakuna, a wholly owned subsidiary, is an award-winning CBD-products company, currently nominated for "Best Hemp-Derived CBD Product" by the California Cannabis Awards after winning the DOPE Magazine Best New Product award for Southern California in the non-cannabis/non-tech category in 2017. Hakuna was also just awarded "Runner Up" at the Los Angeles Coffee & Donut Festival People's Choice Coffee Awards for 2019. Hakuna generates significant revenues with a substantial distribution footprint, including over 110 established retail distribution partners across over 20 states in the domestic US market.

CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the issuance of two U.S. Patents: No. 10,639,339 and 10,624,940. These patents represent an expansion of CURE’s existing “product by process” patents for obtaining multiple unique cannabis concentrates using super critical fluid extraction (SCFE). These include cannabinoid concentrates enriched in cannabidiol (CBD), tetrahydrocannabinol (THC) and cannabigerol (CBG), a non-psychoactive cannabinoid which has shown promising therapeutic activity in animal studies in areas such as inflammatory bowel disease, cancer and infectious diseases.

“Adding CBG to our SCFE patent portfolio aligns with the latest research and early clinical evidence supporting its therapeutic benefit,” said Rob Davidson, CEO of CURE Pharmaceutical. “We continue to expand this portfolio to the latest commercial applications for SCFE, providing our patent licensees and their customers expanded IP rights.”
CURE is granting equipment manufacturers, cannabis processing companies and cannabinoid drug developers licenses to its portfolio of issued and pending process and composition patents for isolating cannabinoids using an advanced SCFE technology utilizing carbon dioxide as the solvent. While the patents cover the incorporation of cannabis extracts into multiple dosage forms, CURE has retained all rights to applying these methods in oral thin films.

The two patents cover the extraction and purification of cannabis plant material, as well as subsequent processing of cannabis extracts for drug formulation. This extraction and fractioning of bioactive cannabinoid molecules allows for the integration of these molecules into dosage forms.

Global Trac Solutions, Inc. (OTC: PSYCannounced that they have engaged with a variety of key industry experts in an effort to plan and prepare for the Company’s intended initial launch set for May 2020. Such efforts have included identifying and establishing strategic partnerships with various individuals and companies whom PSYC will look to collaborate with over the next several weeks and months. The Company will be working on collaborations in the areas of media, website and brand strategy as it positions itself for what it anticipates to be a very effective launch into the emerging business sector of psychedelic medicine.

“In recent weeks we have witnessed our world and our daily lives change significantly as a result of the ongoing COVID-19 pandemic. We have also seen a steady increase in studies and overall focus surrounding a variety of alternative medicines and treatments, including those associated with psychedelics based on the possible benefits for treating anxiety, depression, PTSD, and more. Most recently Rolling Stone Magazine published an interesting article surrounding Swiss chemist Albert Hoffmann’s psychedelic discovery, and in it they state, ‘More recently, Silicon Valley billionaires have been examining the profitability of the industry, neuro-pharmaceutical corporations are developing commercial psychedelic compounds, and the Wall Street Journal is covering psychedelic startups.’ We were fortunate to watch the cannabis industry grow into a sustainable marketplace for both medicinal and recreational use. Part of that journey surrounded research and development including working alongside industry experts to gain the knowledge and understanding needed to service that industry. We will be embarking on the same path for psychedelic medicine by engaging with industry experts, which will likely expand to a new advisory board and a more defined approach, which will result in a unique plan to engage this market,” said Vanessa Luna, CEO of PSYC.

PSYC is at the forefront of psychedelic medicine, we will work with several ancillary businesses to provide a network of resources for our current subscribers, while expanding that network to those pioneers advocating for change and legislation within this arena.

MariMed Inc. (OTCQX: MRMDannounced today that Betty's Eddies™, its proprietary, in-house award-winning national cannabis brand, will now be available for retail purchase in Nevada. The expansion is part of MariMed’s plan to increase the licensing and distribution of its proprietary Brands and Products into high-growth legal state markets.

Betty’s Eddies has been one of the top performing cannabis brands in multiple states across the country, earning the LeafLink award for Best Selling Medical Product in 2019.  Betty's Eddies are gluten-free, vegan fruit chews made from organically grown fruits and vegetables. Containing full spectrum cannabis oil, Betty’s Eddies are produced in a wide variety of dosages and flavors, also offering limited edition varieties by market. Betty’s Bedtime variety has proven to be a top seller in all markets, helping our customers achieve much needed rest and sleep.

In Nevada, MariMed has partnered with Solace Holdings at their state-of-the-art licensed production and manufacturing facility in Las Vegas.  A variety of Betty’s Eddies are now being sold in Nevada, and can be found at Nuwu Dispensary in Elko, Nevada, with several more retail locations to be added this month.

Ryan Crandall, Chief Product Officer and SVP of Sales at MariMed, Inc., commented, "With a successful launch in the Massachusetts market and continued growth in Maryland and Rhode Island, Betty's Eddies has achieved substantial sales growth through the last quarter of 2019 into the first quarter of 2020. The Betty’s brand is one of the most popular cannabis brands in the United States today, with innovative new varieties appealing to a wide range of consumer preferences. As we continue to grow into new markets, we have the opportunity to serve a broader consumer profile and therefore to evolve our product offerings in line with the market demand.”

According to BDS Analytics, Nevada surpassed retail sales expectations in its first year of adult-use sales, and sales are expected to surpass $1.2 billion by 2022. With over 45 million visitors a year from all over the world, Nevada is a key market to building an internationally recognized cannabis brand.

Bob Fireman, CEO of MariMed, Inc., commented, “As the cannabis marketplace continues to grow and cannabis consumers explore new and health-focused consumption options, we believe demand for our brands in Nevada and across our other markets will grow in lock step. MariMed is dedicated to producing the safest, highest quality products and we are excited to introduce them to Nevada adult-use consumers.”

CannaTrac® Technology, Inc., the leading cashless payment solution for the cannabis and hemp industries, announced today that the Company is accepting applications for retailers looking to adopt the CannaCard® cashless payment system in Illinois, California, Florida and Ohio.

“We are thrilled to be accepting applications from retailers and dispensaries looking to adopt the CannaCard cashless payment platform in California, Illinois, Florida and Ohio,” said CannaTrac Vice Chairman and CEO Thomas Gavin IV. “As we continue bringing more retailers on to the CannaCard system, we look forward to doing our part to increase health and safety standards during these trying times for both consumers and retailers.”

By offering CannaCard®, retailers are improving consumer experience through convenience, increasing safety and providing a healthier environment for employees, consumers and the community through contactless payments. Retailers interested in adopting the CannaCard® can apply at https://cannatrac.com/apply/. CannaCard® applications serve a dual purpose by allowing cannabis businesses to apply for both acceptance into the cashless payment software system and a hard-to-come-by bank account with one form.

In the coming months, CannaTrac expects to launch the CannaCard® in several additional high demand markets across the U.S.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

No comments:

Post a Comment